RxWires

Company

Lundbeck

Lundbeck has 34 drugs tracked on RxWires: 6 post-market, 2 approved, 12 in Phase 3, 7 in Phase 2, 7 in Phase 1.

Pipeline

DrugPhaseIndication
SertindolePost-MarketSchizophrenia
EscitalopramPost-MarketPostoperative Pain
RasagilinePost-MarketEarly-stage Parkinson's Disease
EptinezumabPost-MarketMigraine
losartan (drug)Post-MarketAlcoholic Liver Cirrhosis
VortioxetinePost-MarketMDD
SABRILApproved
VYEPTIApproved
IdalopirdinePhase 3Alzheimer's Disease
BrexpiprazolePhase 3Major Depressive Disorder
Aripiprazole and aripiprazole once-monthlyPhase 3Schizophrenia
DesmoteplasePhase 3Stroke
MK0928, gaboxadol / Duration of Treatment - 6 weeksPhase 3Primary Insomnia
Vortioxetine 10-20 mgPhase 3Major Depressive Disorder
NalmefenePhase 3Alcohol Dependence
Lu AF35700Phase 3Treatment-resistant Schizophrenia
AmlenetugPhase 3Multiple System Atrophy
Intravenous Carbamazepine (IV CBZ)Phase 3Epilepsy
gaboxadolPhase 3Primary Insomnia
RisperidonePhase 3Schizophrenia
Lu AA24530Phase 2Major Depressive Disorder
Lu AG13909Phase 2Cushing's Disease
AsedebartPhase 2Adrenal Hyperplasia, Congenital
Lu AF28996Phase 2Parkinson's Disease
Lu AG09222Phase 2Migraine
Lu AF82422Phase 2Multiple System Atrophy
Lu AA24493Phase 2Friedreich's Ataxia
Drug CocktailPhase 1Healthy
Lu AG06474Phase 1Healthy
Lu AF35700 5 mg clinical formulationPhase 1Healthy
Lu AG22515Phase 1Thyroid Eye Disease
Vortioxetine 10 mg single dosePhase 1Pharmacokinetics
Lu AF11167Phase 1Schizophrenia
Lu AH69593Phase 1

Latest

Follow Lundbeck on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.

Follow free

Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.